FR2403078A1 - Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic - Google Patents
Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnosticInfo
- Publication number
- FR2403078A1 FR2403078A1 FR7728193A FR7728193A FR2403078A1 FR 2403078 A1 FR2403078 A1 FR 2403078A1 FR 7728193 A FR7728193 A FR 7728193A FR 7728193 A FR7728193 A FR 7728193A FR 2403078 A1 FR2403078 A1 FR 2403078A1
- Authority
- FR
- France
- Prior art keywords
- solvent
- substances
- cosmetic
- pharmaceutical
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000002537 cosmetic Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 239000002904 solvent Substances 0.000 abstract 4
- 239000000126 substance Substances 0.000 abstract 3
- 239000013081 microcrystal Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- 238000001816 cooling Methods 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 239000011872 intimate mixture Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0283—Matrix particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/652—The particulate/core comprising organic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Abstract
L'invention a pour objet un procédé de préparation de formes pharmaceutiques, cosmétiques ou de diagnostic par cryodessiccation d'une ou de substances en solution ou en suspension dans un solvant ou un mélange de solvants, caractérisé en ce que l'on refroidit localement et progressivement de manière contrôlée la solution ou la suspension tout en l'agitant de façon à provoquer la naissance de microcristaux de solvant qui sont mis en suspension dans le liquide restant jusqu'à obtenir un système complexe microcristallin de viscosité élevée composé essentiellement de microcristaux isolés de solvant en mélange intime avec des phases liquides interstitielles hautement concentrées en les substances initialement présentes, on durcit le système complexe microcristallin par refroidissement poussé et on lyophilise. Ce procédé permet d'obtenir notamment des formes lyophilisées ayant une vitesse de dissolution ou de dispersion plus grandes, ainsi que des compositions lyophiles des substances normalement incompatibles.
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7728193A FR2403078A1 (fr) | 1977-09-19 | 1977-09-19 | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic |
US05/875,542 US4178695A (en) | 1977-09-19 | 1978-02-06 | New process for preparing pharmaceutical, cosmetic or diagnostic formulations |
IE1341/78A IE47020B1 (en) | 1977-09-19 | 1978-07-04 | Improvements in or relating to a new process for preparing pharmaceutical, cosmetic or diagnostic formulations |
SE7808007A SE444645B (sv) | 1977-09-19 | 1978-07-20 | Forfarande for framstellning av farmaceutiska, kosmetiska eller diagnostiska preparat genom frystorkning |
DK333678A DK154528C (da) | 1977-09-19 | 1978-07-26 | Fremgangsmaade til fremstilling af farmaceutiske, kosmetiske eller diagnostiske praeparater |
GB7832497A GB2004182B (en) | 1977-09-19 | 1978-08-07 | Process for preparing pharmaceutical cosmetic or diagnostic formulations |
JP10903678A JPS5495720A (en) | 1977-09-19 | 1978-09-05 | Production of medicines * cosmetics and diagnostic composition |
IT51099/78A IT1106901B (it) | 1977-09-19 | 1978-09-15 | Procedimento per produrre forme farmaceutiche cosmetiche o di diagnostica |
CA311,409A CA1097209A (fr) | 1977-09-19 | 1978-09-15 | Procede pour la preparation de produits cosmetiques, pharmaceutiques ou de diagnostic |
DE19782840461 DE2840461A1 (de) | 1977-09-19 | 1978-09-16 | Verfahren zur herstellung von arzneimittelzubereitungen, kosmetischen oder diagnostischen praeparaten durch gefriertrocknen |
CH973478A CH633445A5 (fr) | 1977-09-19 | 1978-09-18 | Procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic. |
BE190539A BE870548A (fr) | 1977-09-19 | 1978-09-18 | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic |
ES473459A ES473459A1 (es) | 1977-09-19 | 1978-09-18 | Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes |
LU80251A LU80251A1 (fr) | 1977-09-19 | 1978-09-18 | Nouveau procede de preparation de formes pharmaceutiques,cosmetiques ou de diagnostic |
NLAANVRAGE7809522,A NL186675C (nl) | 1977-09-19 | 1978-09-19 | Werkwijze voor het bereiden van farmaceutische, cosmetische en diagnostische materialen. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7728193A FR2403078A1 (fr) | 1977-09-19 | 1977-09-19 | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2403078A1 true FR2403078A1 (fr) | 1979-04-13 |
FR2403078B1 FR2403078B1 (fr) | 1981-07-03 |
Family
ID=9195532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7728193A Granted FR2403078A1 (fr) | 1977-09-19 | 1977-09-19 | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic |
Country Status (15)
Country | Link |
---|---|
US (1) | US4178695A (fr) |
JP (1) | JPS5495720A (fr) |
BE (1) | BE870548A (fr) |
CA (1) | CA1097209A (fr) |
CH (1) | CH633445A5 (fr) |
DE (1) | DE2840461A1 (fr) |
DK (1) | DK154528C (fr) |
ES (1) | ES473459A1 (fr) |
FR (1) | FR2403078A1 (fr) |
GB (1) | GB2004182B (fr) |
IE (1) | IE47020B1 (fr) |
IT (1) | IT1106901B (fr) |
LU (1) | LU80251A1 (fr) |
NL (1) | NL186675C (fr) |
SE (1) | SE444645B (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1209477A (fr) * | 1981-03-26 | 1986-08-12 | Bruce E. Haeger | Compose comprenant une preparation lyophilisee de derive de la penicilline |
US4429542A (en) * | 1981-08-10 | 1984-02-07 | Hoxan Corporation | Method of freezing fertilized ova, spermatozoa or the like and apparatus therefor |
JPS58154547A (ja) * | 1982-03-09 | 1983-09-14 | Nippon Shinyaku Co Ltd | アズレン誘導体の安定化法 |
ES525492A0 (es) * | 1982-09-10 | 1985-02-01 | Glaxo Group Ltd | Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. |
FR2539626B2 (fr) * | 1983-01-25 | 1985-06-21 | Lafon Labor | Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede |
US4642903A (en) * | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
US4712310A (en) * | 1986-09-15 | 1987-12-15 | E. I. Du Pont De Nemours And Company | Co-spray technique |
IL86892A (en) * | 1987-07-08 | 1993-04-04 | Lafon Labor | Filter comprising a material obtained by freeze-drying, its preparation and its use, especially in pharmacy |
JP2865320B2 (ja) * | 1989-08-07 | 1999-03-08 | 株式会社資生堂 | 固型化粧料組成物 |
FR2670675B1 (fr) * | 1990-12-20 | 1993-04-16 | Lafon Labor | Procede de preparation de formes pharmaceutiques stables a base d'acide acetylsalicylique ou de ses sels. |
IL101007A (en) * | 1992-02-18 | 1997-08-14 | Pharmos Ltd | Dry stable compositions prepared by lyophilization |
FR2702968B1 (fr) * | 1993-03-23 | 1995-06-23 | Lafon Labor | Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation . |
DE4342091A1 (de) * | 1993-12-09 | 1995-06-14 | Asta Medica Ag | Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten |
US20040013613A1 (en) * | 2001-05-18 | 2004-01-22 | Jain Rajeev A | Rapidly disintegrating solid oral dosage form |
US8236352B2 (en) | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
US6316029B1 (en) | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
RU2756946C2 (ru) * | 2001-01-26 | 2021-10-07 | Мерк Шарп И Доум Корп. | Применение замещенных азетидинонов для лечения ситостеролемии |
BR0206639A (pt) * | 2001-01-26 | 2004-02-25 | Schering Corp | Combinações de inibidor(es) da absorção do esterol com modificador(es) do sangue para o tratamento de condições vasculares |
DK1413331T3 (da) * | 2001-01-26 | 2007-12-10 | Schering Corp | Kombinationer af peroxisomproliferatoraktiveret receptor (PPAR)-aktivatoren fenofibrat og sterolabsorptionsinhibitoren ezetimib til vaskulære indikationer |
US7071181B2 (en) * | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
DE60220269T2 (de) * | 2001-01-26 | 2008-01-17 | Schering Corp. | Kombinationen eines hemmers der sterolabsorption und eines kardiovaskulären wirkstoffes zur behandlung von kardiovaskulären indikationen |
EP1353695A2 (fr) * | 2001-01-26 | 2003-10-22 | Schering Corporation | Combinaisons d'acide nicotinique et de derives de ce dernier, inhibiteur(s) d'absorption de sterols et traitements de conditions vasculaires |
DE60221798T2 (de) * | 2001-01-26 | 2008-06-05 | Schering Corp. | Kombinationen von gallensäure sequestriermitteln und hemmern der sterol absorption zur behandlung von kardiovaskulären indikationen |
EP1392287B8 (fr) * | 2001-05-25 | 2007-01-10 | Schering Corporation | Usage de dérivés de l'azétidinone pour le traitement de la maladie d' Alzheimer. |
DK1429756T3 (da) * | 2001-09-21 | 2007-03-19 | Schering Corp | Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer |
US7056906B2 (en) * | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
US20030119808A1 (en) * | 2001-09-21 | 2003-06-26 | Schering Corporation | Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects |
DE60229406D1 (de) * | 2001-09-21 | 2008-11-27 | Schering Corp | Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en) |
US7053080B2 (en) * | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
DE60222160T2 (de) * | 2001-10-12 | 2008-06-12 | Elan Pharma International Ltd., Athlone | Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung |
AU2003222027A1 (en) * | 2002-03-20 | 2003-10-08 | Elan Pharma International Limited | Fast dissolving dosage forms having reduced friability |
MXPA05004811A (es) * | 2002-11-06 | 2005-07-22 | Schering Corp | Inhibidores de absorcion de colesterol para el tratamiento de trastornos autoinmunes. |
US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
JP2006519869A (ja) * | 2003-03-07 | 2006-08-31 | シェーリング コーポレイション | 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用 |
MXPA05009501A (es) | 2003-03-07 | 2005-10-18 | Schering Corp | Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia. |
US7235543B2 (en) | 2003-03-07 | 2007-06-26 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
EP1626742A1 (fr) * | 2003-05-22 | 2006-02-22 | Elan Pharma International Limited | Sterilisation de dispersions d'agents actifs particulaires au moyen de rayons gamma |
EP1680189A2 (fr) * | 2003-11-05 | 2006-07-19 | Schering Corporation | Combinaisons de modulateurs lipidiques et d'azetidinones substituees et traitements d'affections vasculaires |
NZ548331A (en) * | 2004-01-28 | 2010-03-26 | Unilever Plc | Porous bodies and method of production thereof |
US7491263B2 (en) | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
EP1870649A1 (fr) | 2006-06-20 | 2007-12-26 | Octapharma AG | Lyophilisation visant à obtenir une humidité résiduelle déterminée par énergie de désorption aux niveaux limités |
US20090238867A1 (en) * | 2007-12-13 | 2009-09-24 | Scott Jenkins | Nanoparticulate Anidulafungin Compositions and Methods for Making the Same |
FR2945950A1 (fr) | 2009-05-27 | 2010-12-03 | Elan Pharma Int Ltd | Compositions de nanoparticules anticancereuses et procedes pour les preparer |
IL297338A (en) | 2020-04-16 | 2022-12-01 | Tavanta Therapeutics Hungary Incorporated | Methods and preparations for the treatment of prostate cancer |
CN114532542A (zh) * | 2022-02-24 | 2022-05-27 | 山东坦途农业科技有限公司 | 一种夹心冻干赋型制剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2984992A (en) * | 1954-07-28 | 1961-05-23 | Union Carbide Corp | Apparatus for freeze dehydration of liquid bearing solids |
FR2036890A1 (fr) * | 1969-04-15 | 1970-12-31 | Orsymonde | |
NL6915749A (en) * | 1969-10-17 | 1971-04-20 | Powdered products from fruit and vegetable juices aqs - vegetable extracts such as coffee, tea, etc having porous | |
FR2068447A1 (en) * | 1969-11-26 | 1971-08-27 | Orsymonde | Dehydrated pharmaceutical comps by - lyophilisation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3309779A (en) * | 1966-02-02 | 1967-03-21 | Fmc Corp | Dehydration of solids-bearing liquids |
GB1190319A (en) * | 1968-08-15 | 1970-05-06 | George Jarvis Tooby | Method for Dehydrating Materials |
DE1900995A1 (de) * | 1969-01-09 | 1970-08-27 | Struthers Scient And Internat | Gefriertrocknungsverfahren fuer Nahrungsmittel und dabei erhaltene Produkte |
US3673698A (en) * | 1970-11-25 | 1972-07-04 | Albert S Guerard | Process for freeze drying with carbon dioxide |
JPS503381A (fr) * | 1973-05-11 | 1975-01-14 | ||
JPS506532A (fr) * | 1973-05-22 | 1975-01-23 |
-
1977
- 1977-09-19 FR FR7728193A patent/FR2403078A1/fr active Granted
-
1978
- 1978-02-06 US US05/875,542 patent/US4178695A/en not_active Expired - Lifetime
- 1978-07-04 IE IE1341/78A patent/IE47020B1/en not_active IP Right Cessation
- 1978-07-20 SE SE7808007A patent/SE444645B/sv not_active IP Right Cessation
- 1978-07-26 DK DK333678A patent/DK154528C/da not_active IP Right Cessation
- 1978-08-07 GB GB7832497A patent/GB2004182B/en not_active Expired
- 1978-09-05 JP JP10903678A patent/JPS5495720A/ja active Granted
- 1978-09-15 CA CA311,409A patent/CA1097209A/fr not_active Expired
- 1978-09-15 IT IT51099/78A patent/IT1106901B/it active
- 1978-09-16 DE DE19782840461 patent/DE2840461A1/de active Granted
- 1978-09-18 BE BE190539A patent/BE870548A/fr not_active IP Right Cessation
- 1978-09-18 LU LU80251A patent/LU80251A1/fr unknown
- 1978-09-18 ES ES473459A patent/ES473459A1/es not_active Expired
- 1978-09-18 CH CH973478A patent/CH633445A5/fr not_active IP Right Cessation
- 1978-09-19 NL NLAANVRAGE7809522,A patent/NL186675C/xx not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2984992A (en) * | 1954-07-28 | 1961-05-23 | Union Carbide Corp | Apparatus for freeze dehydration of liquid bearing solids |
FR2036890A1 (fr) * | 1969-04-15 | 1970-12-31 | Orsymonde | |
NL6915749A (en) * | 1969-10-17 | 1971-04-20 | Powdered products from fruit and vegetable juices aqs - vegetable extracts such as coffee, tea, etc having porous | |
FR2068447A1 (en) * | 1969-11-26 | 1971-08-27 | Orsymonde | Dehydrated pharmaceutical comps by - lyophilisation |
Also Published As
Publication number | Publication date |
---|---|
CH633445A5 (fr) | 1982-12-15 |
IT7851099A0 (it) | 1978-09-15 |
NL7809522A (nl) | 1979-03-21 |
JPS62884B2 (fr) | 1987-01-10 |
IT1106901B (it) | 1985-11-18 |
JPS5495720A (en) | 1979-07-28 |
DK154528C (da) | 1989-04-10 |
IE47020B1 (en) | 1983-11-30 |
NL186675C (nl) | 1991-02-01 |
DE2840461C2 (fr) | 1988-10-06 |
LU80251A1 (fr) | 1979-03-07 |
SE7808007L (sv) | 1979-03-20 |
IE781341L (en) | 1979-03-19 |
GB2004182B (en) | 1982-03-24 |
FR2403078B1 (fr) | 1981-07-03 |
SE444645B (sv) | 1986-04-28 |
DK154528B (da) | 1988-11-21 |
NL186675B (nl) | 1990-09-03 |
DK333678A (da) | 1979-03-20 |
ES473459A1 (es) | 1979-10-16 |
DE2840461A1 (de) | 1979-03-29 |
CA1097209A (fr) | 1981-03-10 |
GB2004182A (en) | 1979-03-28 |
US4178695A (en) | 1979-12-18 |
BE870548A (fr) | 1979-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2403078A1 (fr) | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic | |
DE69719496T2 (de) | N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULPHONYLPROPYLAMID und sein NATRIUMSALZ ALS PRO-PHARMAKON VON COX-2 INHIBITOREN | |
Kurland et al. | The Potentiating Effect of ACTH and of Cortisone on Pressor Response to Intravenous Infusion of L-Nor-Epinephrine. | |
FR2356669A1 (fr) | Procede de separation des sterols | |
FR2361145A1 (fr) | Procede de preparation d'une emulsion | |
NO126475B (fr) | ||
FR2400889A1 (fr) | Procede de preparation d'emulsions eau-dans-l'huile ou huile-dans-l'eau a faible teneur en eau et contenant de la poudre de polyethylene, et emulsions ainsi obtenues | |
Swank et al. | Effects of fat meals and heparin on blood plasma composition as shown by paper chromatography. | |
BE886486A (fr) | Forme pharmaceutique "gel" contenant l'acide 2-(3-benzoyl-phenyl)-propionique et son utilisation en therapeutique pour un usage local | |
IL39924A (en) | Hormone isolated from the parathyroid gland,its preparation and compositions containing it | |
FR2388073A1 (fr) | Procede de production de cuir de suede synthetique | |
Harwood | Effect of Certain Physical Factors on the In Vitro Testing of Anthelmintics. | |
CH648302A5 (fr) | Lactates du 4'-(9-acridinylamino-methanesulf-m-anidiside, leur procede de production et composition pharmaceutique les contenant. | |
DE406207C (de) | Verfahren zur Darstellung eines Kondensationsproduktes aus 2-Aminopyridin | |
DE935668C (de) | Verfahren zur Herstellung geruch- und geschmackloser Guajacol-Verbindungen | |
DE254091C (fr) | ||
DE752571C (de) | Verfahren zur Herstellung von Verbindungen des Guajacols | |
DE1795461A1 (de) | D-Azlactone und Verfahren zu ihrer Herstellung | |
DE19938475A1 (de) | Verfahren zur Herstellung von Hexamethyldisilazan | |
DE2727554C2 (de) | Kontinuierliche Verfahren zur Stabilisierung von unter Druck abgekochter, wasserfeuchter, als Lack-Collodiumwolle verwendbarer Nitrocellulose | |
SU148067A1 (ru) | Способ получени 9-производных 9-10-дигидроантрацена | |
DE941685C (de) | Verfahren zur Herstellung eines protrahiert wirksamen Kallikrein-Praeparates | |
DE2010191C (de) | Verfahren zur Herstellung eines stabilen Cytochrom c enthaltenden Pra parats | |
FR2441612A1 (fr) | Procede de purification du tryptophane et de derives du triptophane | |
Uchiyama | STUDIES ON ADRENAL ENUCLEATION 2. REGENERATION OF CORTEX AFTER ENUCLEATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property |